Lambipol

Lamotrigine, the active ingredient in Lambipol, is an Anticonvulsant presented as an oral dosage form for oral use. It is used to control partial seizures, generalized tonic‑clonic seizures and as maintenance therapy for bipolar disorder in adults and adolescents. GNH USA supplies Lambipol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is indicated for several neurological and psychiatric conditions that involve abnormal neuronal excitability. - Partial seizures: reduces seizure frequency and severity in focal epilepsy. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes in generalized epilepsy. - Bipolar disorder (maintenance therapy): stabilises mood and decreases the risk of depressive and manic episodes.

Lamotrigine may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Dizziness: transient feeling of light‑headedness. - Headache: mild to moderate intensity. - Nausea: occasional upset stomach. - Rash: non‑serious skin irritation. - Insomnia: difficulty falling or staying asleep. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Aseptic meningitis: inflammation of the meninges without infection. - Severe hypersensitivity reactions: including fever, lymphadenopathy, and organ involvement. - Hematologic abnormalities: such as leukopenia or thrombocytopenia. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating Lamotrigine therapy, consider the following precautions. - Pregnancy: Category C; discuss potential risks and benefits with a healthcare professional. - Breastfeeding: Lamotrigine is excreted in breast milk; evaluate infant exposure. - Renal impairment: dose adjustment may be required in reduced kidney function. - Hepatic impairment: monitor liver function tests regularly. - Concomitant valproate: increased risk of serious skin reactions; monitor closely. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Lamotrigine can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine plasma levels, raising risk of severe rash. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy. - Phenobarbital: lowers lamotrigine levels, may require dose adjustment.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, leading to loss of seizure control. - Serotonergic agents: combined use may increase risk of serotonin syndrome. - Other antiepileptics (e.g., phenytoin, primidone): may modestly affect lamotrigine metabolism. - Antifungal azoles (e.g., fluconazole): can slightly raise lamotrigine concentrations.